Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Test can spare breast cancer patients the need for chemotherapy

The approximately 5,200 women diagnosed with breast cancer each year in Austria are divided into subgroups. Hormone-receptor positive tumors are the most common type of breast cancer. Their growth is supported by the female sexual hormone estrogen. The standard therapy for this kind of tumor is the so-called anti-hormonal therapy.

Up until now, further treatment was determined on the basis of clinical parameters such as the size of the tumor, the occurrence of lymph nodes, age and hormone sensitivity.  In order to reduce the risk of having a relapse, doctors often decide to carry out chemotherapy over a period of months, with all the related side effects such a tiredness, loss of hair, nausea and other symptoms.

In this regard, this type of therapy would not be necessary in some cases, in light of the fact that some patients would anyway have had a low relapse risk. This risk is now identified by the Prosigna(R) test. These patients have a risk of less than ten percent over the next ten years, which applies to about one third of all breast cancer patients. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

Austria Map

Find the perfect location for your company

Thanks to a fantastic mindset, our employees at the Villach site have built up a unique expertise which helps us to further strengthen our position on the global market. We fuse high-performance manufacturing with research and development in the field of power electronics. In addition to a very good cooperation with partners and networks, a well-developed landscape of 'talent factories' ranging from higher technical colleges to universities, we as a company also value the outstanding model of research promotion which exists in Austria.

Infineon

Logo Infineon
More testimonials

news from the business location Austria

Medical University of Vienna: New therapy option doubles the life span of B-cell lymphoma patients

The so-called CAR-T cell therapy is a promising option for treating around one fifth of patients with diffuse large B-cell lymphoma.

Ski Tourism as an Attractive Business Driver in Austria

Famous for its culture and unspoiled natural environment, Austria attracts vacationers and tourism companies from all over the world. One major advantage is the central location in the heart of Europe and the related good accessibility.

More news All blog posts